Long-term toxicity profile of trastuzumab emtansine (T-DM1): A multicenter real-life study.Giuseppe Buono, Grazia Arpino, Alessandra Fabi et al.|Journal of Clinical Oncology|2019Cited by 6
BRCA1 and 2 Mutations and Efficacy of Pembrolizumab-Based Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Real-World Multicenter AnalysisPalma Fedele, Gennaro Gadaleta‐Caldarola, Raffaele Ardito et al.|Journal of Clinical Medicine|2025Cited by 4
Impact of Chemotherapy Dose Intensity on Pathological Complete Response in Pembrolizumab-Treated Early Triple-Negative Breast Cancer: A Real-World Multicenter AnalysisPalma Fedele, Gennaro Gadaleta‐Caldarola, Luigia Stefania Stucci et al.|Cancers|2025Cited by 3
BRCA1/2 Mutations and Efficacy of Pembrolizumab-Based Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Real-World Multicenter AnalysisPalma Fedele, Gennaro Gadaleta‐Caldarola, Alessandro Rizzo et al.|Preprints.org|2025Cited by 1